March 28, 2017 6:54 PM ET


Company Overview of Galenika a.d.

Company Overview

Galenika a.d. manufactures and markets pharmaceutical products in Europe, Asia, and Africa. It offers generic medicines and drugs, pharmaceutical raw materials, parapharmaceuticals, dietetic supplements, medical devices, and dental products; and contract manufacturing and laboratory services. The company provides its products in the form of tablets, capsules, units of sterile preparations, bottles of syrups and powders for oral suspensions, medicinal ointments and preparations for local applications, and dressings. It offers its products through representative offices and affiliates in Novi Sad, Niš, and Kragujevac, Serbia; Banjaluka and Sarajevo, Bosna and Hercegovina; Macedonia; Montenegro...

Batajnièki drum bb

Belgrade,  11080


Founded in 1945


381 11 307 1000


381 11 307 1395

Key Executives for Galenika a.d.

General Manager
Compensation as of Fiscal Year 2016.

Galenika a.d. Key Developments

Serbia Cancels Sale Of Galenika As Talks With British-Russian Consortium Fail

Serbia's government has cancelled a procedure for the privatisation of Galenika a.d. Serbia's government has cancelled a procedure for the privatisation of Galenika at the proposal of a commission that held negotiations with the only bidder, a British-Russian consortium, government documents showed. "The privatisation process of Galenika via a strategic partnership model has been declared unsuccessful," the government said in a document. The government was looking to find a strategic partner in Galenika by a launching a tender for a 25% stake in the company for a minimum of €7 million. The British-Russian consortium was the only bidder left in the race after the bids submitted by EMS S.A., Cadila Pharmaceuticals Limited were rejected over procedural flaws.

A British-Russian Consortium Mulls Acquisition Of 25% Stake In Galenika

A British-Russian consortium is seeking acquisition of 25% stake in Galenika a.d. A British-Russian consortium said on February 14, 2017, that they are close to an agreement for the purchase of 25% of Galenika. The consortium comprising Frontier Pharma Limited and Russian LLC NPA Petrovax Pharm aims to transform Galenika into a regional pharmaceutical leader and plans to invest up to €30 million ($31.8 million) in quality improvements, technological upgrades and new product development which will allow the company to deliver high-quality and affordable products, it told SeeNews in an e-mailed statement. Banks are supportive of a deal with Frontier Pharma and NPA Petrovax Pharm and they expressed their support to Serbia's economy ministry on February 13, 2017, so there are no hurdles for the deal to be completed in the next two or three weeks, the consortium added. "Of all the options currently available to Galenika, a transaction with the consortium is by far the best alternative for the long-term sustainability and growth of Galenika. We look forward to continuing our productive discussions with the Republic of Serbia and being given the opportunity to transform Galenika into a world-class pharmaceutical company," the consortium added. The potential buyer has reportedly offered €7 million for the 25% shareholding interest.

Galenika Received Bids From 3 Companies

Galenika a.d. received bids for sale of 25% stake. Bidders include Cadila Pharmaceuticals Limited, EMS S.A., Frontier Pharma Limited, NPO Petrovax Pharm LLC. The bids will be opened on Friday, July 29, 2016, the ministry said in a statement. The bids will be ranked according to the number of jobs proposed and the plans for recapitalization of the company as the two most important criteria, the statement reads. The government will then announce the best bidder and it will have up to 90 days to negotiate a final deal with it.

Similar Private Companies By Industry

Company Name Region
Galenika a.d. Europe
Joint stock company for medical goods supply MEDIFARM Europe
Kondirolli Europe
Pharmanova d.o.o Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Galenika a.d., please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at